FIELD: pharmacology.
SUBSTANCE: invention is application of a therapeutic agent for parenteral administration in atopic dermatitis, which is a water-salt solution consisting of fullerene C60, pluronic F-127 and physiological saline, where the components in the agent are in a certain ratio per ml of solution.
EFFECT: reduction of allergic inflammation, skin regeneration improvement.
1 tbl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR ATOPIC DERMATITIS THERAPY BASED ON FULLEREN | 2016 |
|
RU2641041C1 |
| METHOD FOR PRODUCTION OF FULLERENE WATER-SALT DISPERSIONS | 2015 |
|
RU2630561C2 |
| METHOD OF OBTAINING A HIGHLY CONCENTRATED AQUEOUS SOLUTION FULLERENE | 2018 |
|
RU2679257C1 |
| METHOD FOR PRODUCING AQUEOUS NANODISPERSIONS OF FULLEREN | 2013 |
|
RU2548971C2 |
| METHOD FOR ALLERGIC BRONCHIAL ASTHMA TREATMENT, BASED ON CYTOKINES IL-4 AND IL-13 GENES EXPRESSION INHIBITION USING SIRNA MOLECULES | 2016 |
|
RU2615463C1 |
| HEPATOPROTECTIVE AND ANTIOXIDANT DRUG FOR ANIMALS BASED ON AQUEOUS SOLUTION OF FULLERENE C, RESVERATROL AND BETAINE HYDROCHLORIDE | 2020 |
|
RU2770534C1 |
| MEANS FOR THE TREATMENT OF ATOPIC DERMATITIS | 2022 |
|
RU2794841C1 |
| COMPOSITION FOR INTERLEUKINE-4 CYTOKINE GENE SILENCING | 2014 |
|
RU2563989C1 |
| COMPOSITION INHIBITING EXPRESSION OF INTERLEUKIN-4 AND INTERLEUKIN-13 GENES FOR THERAPY OF ALLERGIC RHINITIS | 2018 |
|
RU2710895C1 |
| HYDRATED N-FULLERENE-AMINO ACID DERIVATIVES, METHOD FOR PREPARING THEM AND BASED PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2458046C1 |
